Cyber Letters Caution Foreign Firms Against Drug Claims for Supplements
This article was originally published in The Tan Sheet
Executive Summary
FDA has added a section to its "cyber letters" intended specifically for online foreign firms selling unapproved drug products that notes the items "may not be approved for marketing in this country.